You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : HEALTHCARE EQUIPMENT & SUPPLIES
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. ORCHESTRA BIOMED HOLDINGS INC

Orchestra BioMed Holdings Inc XNAS: OBIO

Orchestra BioMed Holdings Inc Live Share Price Today, Share Analysis and Chart

Download real time

4.39 -0.04 (-0.90%)

New 52W Low in past week

23,327 XNAS Volume

XNAS 20 Mar, 2025 1:09 PM (EDT)

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for Orchestra BioMed Holdings Inc is on 27 Mar 2025 for the purpose of Orchestra BioMed Holdings Inc Fourth Quarter Earnings Results for 2024 See details

Orchestra BioMed Holdings Inc Key Metrics

Default

Market Capitalization

Below industry Median
166

PE TTM

Negative PE TTM
-2.9

PEG TTM

Below industry Median
0.1

Price to Book

Below industry Median
3.6

Institutional holding current Qtr %

Below industry Median
51.4

Revenue Growth Qtr YoY %

High in industry
135.6

Operating Revenue growth TTM %

Negative Operating Revenue growth TTM %
-26.5

Net Profit Qtr Growth YoY %

Negative Net Profit Qtr Growth YoY %
-15.8

Net Profit TTM Growth %

Negative Net Profit TTM Growth %
-25.3

Operating Profit Margin Qtr %

Negative Operating Profit Margin Qtr %
-1,655.7

Operating Profit Margin TTM %

Negative Operating Profit Margin TTM %
-2,270.7

Piotroski Score

Below industry Median
3

Rel Perf vs Sector quarter%

-11.9

ROE Annual %

Negative ROE Annual %
-81.5

RoA Annual %

Negative RoA Annual %
-51.5
All financials are in USD Million and price data in USD
VIEW MORE

11

S

10

W

0

O

2

T

SWOT Analysis

Check P/E Buy Sell Zone

This stock has negative PE


Orchestra BioMed Holdings Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '2623456Actual RevenueAvg. Estimate
Miss

Orchestra BioMed Holdings Inc's Revenue was lower than average estimate 2 times in past 2 years

EPS forecast

Current EPS
-1.5
Avg. Estimate
-1.7
Low Estimate
-1.7
High Estimate
-1.6
Current EPS
Avg. Estimate
Miss

EPS is expected to reduce by 12.2% in FY24

Consensus Recommendation

6 ANALYST Recommendations
BUY

Created with Highcharts 7.2.23Buy3Strong Buy

The consensus recommendation from 6 analysts for Orchestra BioMed Holdings Inc is BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Orchestra BioMed Holdings Inc Stock Analysis

Orchestra BioMed Holdings Inc stock analysis with key metrics, changes, and trends.

Orchestra BioMed Holdings Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$2.76 M23.35%negative

Annual Revenue fell 23.35%, in the last year to $2.76 M. Its sector's average revenue growth for the last fiscal year was 8.72%.

Annual Net Profit$49.12 M6.66%negative

Annual Net Profit fell 6.66% in the last year to $49.12 M. Its sector's average net profit growth for the last fiscal year was 3.53%.

Price to Earning Ratio-2.88-negative

Price to Earning Ratio is -2.88, which is negative.

Stock Price$4.39-17.17%negative

Stock Price fell 17.17% and underperformed its sector by 23.65% in the past year.

Quarterly Revenue$0.99 M135.56%positive

Quarterly Revenue rose 135.56% YoY to $0.99 M. Its sector's average revenue growth YoY for the quarter was 8.57%.

Quarterly Net profit$15.43 M15.85%negative

Quarterly Net profit fell 15.85% YoY to $15.43 M. Its sector's average net profit growth YoY for the quarter was 27.31%.

Debt to Equity Ratio0.02-positive

Debt to Equity Ratio of 0.02 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)-81.47 %-81.47%negative

Return on Equity(ROE) for the last financial year was -81.47%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding16.14 %-0.19%negative

Mutual Fund Holding decreased by 0.19% in the last quarter to 16.14.

Institutional Holding51.42 %0%neutral

Institutional Holding remained the same in the last quarter at 51.42%.

VIEW LESS


Loading data..

Orchestra BioMed Holdings Inc - Company Profile

What does Orchestra BioMed Holdings Inc do?

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Orchestra BioMed Holdings Inc Management structure

All Gross Remunerations are in USD
Mr. David P. Hochman
Chairman of the Board and Chief Executive Officer
6.9 M
2023
Gross Remuneration
Year
Mr. Darren Sherman
President, Chief Operating Officer and Director
6.45 M
2023
Gross Remuneration
Year
Mr. Andrew Taylor
Chief Financial Officer
2.39 M
2023
Gross Remuneration
Year
Mr. Michael Kaswan
Chief Financial Officer
-
2023
Gross Remuneration
Year
Dr. Yuval Mika, Pd.D
General Manager and Chief Technology Officer, Bioelectronic Therapies
-
2023
Gross Remuneration
Year
Ms. Eileen Bailey
Vice President, Quality
-
2023
Gross Remuneration
Year

Orchestra BioMed Holdings Inc Board of directors

All Gross Remunerations are in USD
Dr. Eric A. Rose, M.D.
Independent Director
-
2025
Gross Remuneration
Year
Mr. Christopher Cleary
Independent Director
-
2025
Gross Remuneration
Year

Orchestra BioMed Holdings Inc FAQ

How is Orchestra BioMed Holdings Inc today?
Orchestra BioMed Holdings Inc today is trading in the red, and is down by -0.90% at 4.39.
Orchestra BioMed Holdings Inc is currently trading down -0.90% on an intraday basis. In the past week the stock rose 9.20%. stock has been down -8.54% in the past quarter and fell -17.17% in the past year. You can view this in the overview section.